Our News

Newsletter #3

Jun 2021
Pia Marten youngest CEO with stock market listing, Cannovum stock exchange listing, Sustainable own brand

Newsletter #2

Feb 2021
Handelsblatt Article, Cannovum Market Entry, Fully licensed, and more.

Newsletter #1

Jul 2020
Successful Audit of our cultivator, Chief medical advisor, and more.

Cannovum Newsletter

Get the latest information and insights:

check_circle
Successfully subscribed
Something went wrong while submitting the form.

News and updates

News
September 8, 2021

Cannovum AG expands Supervisory Board and Medical Advisory Board

Priv. Doz. Dr. med. habil. Philipp Sewerin is the new member of the supervisory board as well as the Medical Advisory Board. Dr. Sewerin is a specialist in internal medicine and rheumatology at the university clinic in Düsseldorf.

News
September 6, 2021

Cannovum AG starts European cannabis expansion

Cannovum took the first step and founded Cannovum Iberia LDA, a joint venture between Cannovum and Portuguese entrepreneurs from the cannabis industry.

News
June 29, 2021

Cannovum AG enters the full-spectrum cannabis extract market

Cannovum has signed a supply agreement for full-spectrum cannabis extracts. The extracts are distributed to pharmacies under Cannovum's own brand. 

News
June 24, 2021

Cannovum AG enters supply agreement for medical cannabis with Aurora Europe

Cannovum has entered into a long term supply agreement with Aurora Europe. Starting today, Cannovum will distribute the full range of medical cannabis products offered by Aurora to pharmacies throughout Germany.

News
June 15, 2021

Cannovum AG enters cannabis market segment Dronabinol

Cannovum is pleased to announce a strategic supply partnership for Dronabinol with a European medical cannabis supplier. Products are expected to be sold starting from August as part of the Cannovum brand range.

News
May 6, 2021

Cannovum AG’s direct listing on the Düsseldorf Stock Exchange

First German medical cannabis company listed on the German stock exchange: shares in Cannovum AG can now be traded on the OTC market of the Düsseldorf Stock Exchange.

News
April 21, 2021

First German medical cannabis company to provide a sustainable, sun-grown and chemical-pesticide free product line

Our CEO, Pia Marten, spoke with Krautinvest about Cannovum’s unique place on the German market as the first medical cannabis company to employ this sustainable approach to their own product line.

News
February 12, 2021

Cannovum is now part of the BPC

We are excited to announce our partnership with the BPC, who promote sustainable development of cannabinoid therapies and strengthen the legitimacy of the pharmaceutical cannabinoid industry.

News
January 5, 2021

Handelsblatt

Handelsblatt published an entrepreneur profile that covers the motivation of our CEO Pia Marten behind founding Cannovum AG. Find the article here:

News
December 8, 2020

Market entry Cannovum

With the market entry and the launch of our online shop, Cannovum takes a big step forward to further improve the supply of patients with cannabinoid-based therapies.

News
November 3, 2020

Cannovum welcomes Sanda Bütow as Head of Medical Affairs.

Sandra has 15 years of experience in the healthcare industry and has led the development of the medical affairs department and the education platform "Aurora Academy" for the Canadian manufacturer Aurora.

News
October 17, 2020

Meeting in Berlin with Friedrich Merz (Politician/CDU)

Our CEO Pia Marten met Friedrich Merz and other entrepreneurs in Berlin. The discussion focused on topics like digitalization, entrepreneurship, and promotion of innovation.

News
October 12, 2020

Cannovum received its GMP manufacturing license

This means we can streamline our supply chain by packaging and labeling in Germany.

News
August 10, 2020

Chief Medical Advisor

We are pleased to announce that Dr. med. Dipl.-Chem. Konrad F. Cimander will support us with his expertise in the field of medical cannabis. Learn more about Dr. Cimander on our Medical Advisory Board:

News
July 30, 2020

Fully licensed wholesaler

We are now a fully licensed pharmaceutical wholesaler and ready to make our vision come true! Find our licenses here:

News
July 21, 2020

Moved to Factory Berlin

Cannovum AG has moved to Factory Berlin. We are looking forward to meeting many more innovative companies and expanding our network.

News
June 24, 2020

Cultivator successfully audited

Cannovum performed a successful GMP audit of its first supplier. We ensure that our cultivators adhere to strict EU GMP regulations, highest standards and quality.

News
May 22, 2020

Who is the typical German cannabis patient? (English article)

Pia has released an english translation of her well received Krautinvest.de article. Read about her insights from the BfArM survey on Medium:

News
May 3, 2020

Who is the typical German cannabis patient? (German a

Our CEO and Co-Founder has studied the most comprehensive data on cannabis patients in Germany and shared her insights on Krautinvest.de:

News
April 24, 2020

Cannovum received the pharmaceutical wholesale license

Cannovum reached another milestone! We were granted the pharmaceutical wholesale license (§52a AMG). See our license below:

News
March 15, 2020

Cannovum is an official supporting member of the BvCW

We're happy to be part of the network that connects the cannabis industry in Germany and Europe! Learn more about the BvCW on their website:

News
March 10, 2020

Cannovum is now a member of the VCA

We're proud to announce that we're now an official supporting member of the "VCA", the German association for cannabis dispensing pharmacies.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.